PanGen Biotech Inc. | Cash Flow
Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,367,490.90
2,120,053.20
2,637,912.00
5,125,184.00
7,015,593.00
Depreciation, Depletion & Amortization
876,988.50
974,872.40
1,054,660.00
1,141,962.00
785,899.00
Other Funds
2,156.90
-
-
258.20
3,474.20
Funds from Operations
6,812.10
1,336,948.30
857,314.20
5,821,822.30
2,590,904.60
Changes in Working Capital
748,974.60
3,081.80
749,166.00
1,476,461.00
1,933,068.00
Net Operating Cash Flow
742,162.50
1,340,030.10
1,606,480.20
4,345,361.30
657,836.60
Capital Expenditures
1,890,959.10
2,119,928.40
1,581,343.20
3,464,555.30
2,906,021.10
Sale of Fixed Assets & Businesses
-
-
-
5,450.00
-
Purchase/Sale of Investments
893,503.50
1,013,783.00
941,043.20
4,992,100.00
3,549.10
Net Investing Cash Flow
997,455.60
3,133,711.40
640,300.00
9,075,355.30
7,013,591.10
Issuance/Reduction of Debt, Net
161,439.30
1,763,984.30
705,713.10
2,340,000.00
-
Net Financing Cash Flow
163,596.20
6,425,054.30
705,713.10
26,057,235.80
2,889,317.60
Net Change in Cash
420,430.60
1,952,879.50
1,529,513.90
12,641,262.50
4,786,413.90
Free Cash Flow
304,733.70
1,888,034.90
2,051,544.10
5,873,881.10
2,755,375.20
Other Sources
-
-
-
-
7,000,000.00
Change in Capital Stock
-
8,189,038.70
-
28,397,494.00
2,892,791.80
Exchange Rate Effect
1,541.20
1,566.70
11,553.10
4,743.30
4,303.90
Other Uses
-
-
-
624,150.00
11,104,020.90
About PanGen Biotech
View Profile
